AAAAAA

   
Results: 1-25 | 26-50 | 51-56 |
Results: 51-56/56
ONDASETRON VERSUS METOCLOPRAMIDE FOR PROPHYLAXIS OF NAUSEA AND VOMITING AFTER INTENSIVE CHEMORADIOTHERAPY
Authors: MRSIC M LABAR B NEMET D BOGDANIC V MARAVIC N SNELLER V
Citation: M. Mrsic et al., ONDASETRON VERSUS METOCLOPRAMIDE FOR PROPHYLAXIS OF NAUSEA AND VOMITING AFTER INTENSIVE CHEMORADIOTHERAPY, Experimental hematology, 21(8), 1993, pp. 1133-1133
PROSTAGLANDIN-E(2) FOR PROPHYLAXIS OF ORAL MUCOSITIS FOLLOWING BMT
Authors: LABAR B MRSIC M PAVLETIC Z BOGDANIC V NEMET D AURER I RADMAN I FILIPOVICGRCIC N SERTIC D KALENIC S PRESECKI V
Citation: B. Labar et al., PROSTAGLANDIN-E(2) FOR PROPHYLAXIS OF ORAL MUCOSITIS FOLLOWING BMT, Bone marrow transplantation, 11(5), 1993, pp. 379-382
UMBILICAL-CORD BLOOD TRANSPLANTATION IN A PATIENT WITH PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA
Authors: BOGDANIC V NEMET D KASTELAN A LATIN V PETROVECKI M BRKLJACICSURLAKOVIC L KERHINBRKLJACIC V AURER I KONJA J MRSIC M KALENIC S LABAR B
Citation: V. Bogdanic et al., UMBILICAL-CORD BLOOD TRANSPLANTATION IN A PATIENT WITH PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA, Transplantation, 56(2), 1993, pp. 477-479
PROSPECTIVE PHASE-III STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION(ABMT) NU SHORT INTENSIVE CHEMOTHERAPY (IC) V ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT) DURING 1ST COMPLETE REMISSION (CR) OF ACUTEMYELOGENOUS LEUKEMIA (AML) - RESULTS OF THE EORTC-GIMEMA AML-8A TRIAL
Authors: ZITTOUN R MANDELLI F WILLEMZE R DEWITTE T LABAR B RESEGOTTI L FERRINI PR VISANI G CARONIA F STRYCKMANS P MARMONT A HAYAT M UMLAUFT F ROTOLI B PEETERMANS M PAPA G LEONI P PETTI MC DARDENNE M SOLBU G VEGNA ML SUCIU S
Citation: R. Zittoun et al., PROSPECTIVE PHASE-III STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION(ABMT) NU SHORT INTENSIVE CHEMOTHERAPY (IC) V ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT) DURING 1ST COMPLETE REMISSION (CR) OF ACUTEMYELOGENOUS LEUKEMIA (AML) - RESULTS OF THE EORTC-GIMEMA AML-8A TRIAL, Blood, 82(10), 1993, pp. 10000085-10000085
BONE-MARROW TRANSPLANTATION OR IMMUNOSUPPRESSIVE THERAPY FOR THE TREATMENT OF SEVERE APLASTIC-ANEMIA
Authors: LABAR B BOGDANIC V NEMET D MRSIC M SERTIC D RADMAN I AURER I MARAVIC N SNELLER V ZUPANCICSALEK S
Citation: B. Labar et al., BONE-MARROW TRANSPLANTATION OR IMMUNOSUPPRESSIVE THERAPY FOR THE TREATMENT OF SEVERE APLASTIC-ANEMIA, Blood, 82(10), 1993, pp. 10000092-10000092
EVALUATION OF THE ROLE OF THE PRESENCE OF AN HLA-IDENTICAL SIBLING AND ALLOGENEIC BONE-MARROW TRANSPLANTATION IN THE PROSPECTIVE RANDOMIZEDSTUDY OF THE LEUKEMIA COOPERATIVE GROUPS OF THE EORTC AND GIMEMA
Authors: DEWITTE T KEATING S MANDELLI F WILLEMZE R STRIJCKMANS P PEETERMANS M HAYAT M LABAR B ZWIERZINA H RESEGOTTI L FERRINI PR CARONIA F VISANI G DARDENNE M SOLBU G PETTI M VEGNA M SUCIU S ZITTOUN R
Citation: T. Dewitte et al., EVALUATION OF THE ROLE OF THE PRESENCE OF AN HLA-IDENTICAL SIBLING AND ALLOGENEIC BONE-MARROW TRANSPLANTATION IN THE PROSPECTIVE RANDOMIZEDSTUDY OF THE LEUKEMIA COOPERATIVE GROUPS OF THE EORTC AND GIMEMA, Blood, 82(10), 1993, pp. 10000345-10000345
Risultati: 1-25 | 26-50 | 51-56 |